en
E-mail us
+1-609-604-8303
bd_global@crystalpharmatech.com
 cn

Meet Crystal Pharmatech at Chinese Antibody Society 2024 Annual Conference

Join our team in Boston on Saturday for the Chinese Antibody Society 2024 Annual Conference.

Catch up with Crystal Bio's CSO, Billy Wu, Ph.D., and our new CTO, Ye Gu, Ph.D. We will also be joined by Crystal Pharmatech SME, Ridwan Islam, M. Pharm., Ph.D.

Local SMEs and facilities for innovators in Boston. Let's connect!

BD_Global@CrystalPharmatech.com

Related CRO & CDMO Services

Oral Solid Dosage Forms
Mol2Med™ Integrated Services
pKa/LogP/LogD Measurements
Latest News about Crystal Pharmatech
Characterization and Evaluation of Amorphous Solid Dispersion-Part 2
Technical Articles
16 May 2024
Characterization and Evaluation of Amorphous Solid Dispersion-Part 2
Crystal Bio Appoints Dr. Ye Gu as Co-founder, CTO, and Head of USA BD
News
14 May 2024
Crystal Bio Appoints Dr. Ye Gu as Co-founder, CTO, and Head of USA BD
Characterization and Evaluation of Amorphous Solid Dispersion (ASD) - Part 1
Technical Articles
30 Apr 2024
Characterization and Evaluation of Amorphous Solid Dispersion (ASD) - Part 1
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Technology
Quick Links
About Us Events
Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
Suite B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China, 215123
Sitemap
Privacy Policy
API Form and Solid-State Research
Solid Form Screening and Selection Single Crystal Growth & Structure Determination Solid-State NMR Analysis
Analytical Chemistry
Pre-formulation Studies
Formulation Development
Clinical and Commercial Manufacturing
Technology
Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet
Quick Links
About Us Technical Articles Events
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303
Sitemap
Privacy Policy